BrainsWay Ltd. (NASDAQ: BWAY)
$6.92
+0.0200 ( +0.29% ) 35.4K
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
Market Data
Open
$6.92
Previous close
$6.90
Volume
35.4K
Market cap
$117.99M
Day range
$6.25 - $7.15
52 week range
$2.17 - $7.62
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 1 | Jun 17, 2024 |
6-k | Quarterly Reports | 2 | Jun 17, 2024 |
6-k | Quarterly Reports | 2 | Jun 10, 2024 |
6-k | Quarterly Reports | 2 | Jun 03, 2024 |
6-k | Quarterly Reports | 3 | May 09, 2024 |
6-k | Quarterly Reports | 2 | May 08, 2024 |
6-k | Quarterly Reports | 2 | Apr 17, 2024 |
6-k | Quarterly Reports | 2 | Apr 04, 2024 |
20-f | Annual reports | 124 | Mar 28, 2024 |
6-k | Quarterly Reports | 2 | Mar 18, 2024 |